HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

S-1

SUSPENDED · PHASE1, PHASE2 · Pancreatic Cancer

Unfortunately, other Phase III clinical Study (GEM+S-1 vs GEM vs S-1) have been started in Japan. h

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.